dihexa retracted paper controversy This morning, @novartis announced that del-brax met the primary and key secondary endpoints in the biomarker cohort of the Phase 1/2 FORTITUDE study. The results showed reductions in biomarkers associated with DUX4 How to avoid the stigma
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19



























